Dipesh K. Shah

FDA investigator · also recorded as Ee Es Dipesh Shah

Appears on 29 documents from 2006 to 2026, mostly at sites in India. Most often cites production record review (21 CFR 211.192).

29
Documents on file
5.0
Observations per 483
2006
First seen
2026
Most recent

What they cite most

From 141 observations

Activity by year

2006: 1, 2014: 1, 2017: 1, 2018: 5, 2019: 7, 2020: 2, 2021: 3, 2022: 3, 2023: 3, 2024: 2, 2026: 1

Where

India 27 · China 1 · New York 1

Is Dipesh K. Shah coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

29 documents, newest first
FirmOpen
483 Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao Town, LinhaiApr 24, 2026 · Linhai, China
483 Jagsonpal Pharmaceuticals LtdApr 3, 2024 · Bhiwadi, India
483 Synergene Active Ingredients Private LimitedFeb 17, 2024 · Anakapalli, India
483 GLAND PHARMA LIMITEDAug 26, 2023 · Hyderabad, India
483 Sidmak Laboratories (India) Pvt.Ltd.May 13, 2023 · Dehradun, India
483 Strides Pharma Science LimitedFeb 24, 2023 · Puducherry, India
483 Maiva Pharma Private LimitedOct 29, 2022 · Hosur, India

About this profile

What does Dipesh K. Shah inspect?

Dipesh K. Shah appears on 29 documents on file covering 26 sites, mostly in India.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.67 and 21 CFR 211.68.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Dipesh K. Shah is dated Apr 24, 2026.